Autologous stem cell transplantation improves microcirculation in systemic sclerosis

被引:80
|
作者
Miniati, I. [1 ]
Guiducci, S. [1 ]
Conforti, M. L. [1 ]
Rogai, V. [1 ]
Fiori, G. [1 ]
Cinelli, M. [1 ]
Saccardi, R. [2 ]
Guidi, S. [2 ]
Bosi, A. [2 ]
Tyndall, A. [3 ]
Matucci-Cerinic, M. [1 ]
机构
[1] AOUC, Dept Biomed, Div Rheumatol, DENOthe Ctr, Florence, Italy
[2] AOUC, Bone Marrow Transplantat Unit, Florence, Italy
[3] Univ Basel, Dept Rheumatol, Basel, Switzerland
关键词
ENDOTHELIAL GROWTH-FACTOR; NAILFOLD CAPILLAROSCOPY; RAYNAUDS-PHENOMENON; PULMONARY-FIBROSIS; CYCLOPHOSPHAMIDE; SCLERODERMA; DISORDERS; PLACEBO; DISEASE; ANGIOGENESIS;
D O I
10.1136/ard.2007.082495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In systemic sclerosis (SSc) reduced capillary density decreases blood flow and leads to tissue ischaemia and fingertip ulcers. Nail fold videocapillaro-scopy (NVC) is a diagnostic and follow-up parameter useful to evaluate the severity, activity and the stage of SSc microvascular damage. Autologous haemopoietic stem cell transplantation (HSCT) is a new treatment for patients with severe diffuse cutaneous systemic sclerosis (dcSSc) refractory to conventional therapies. We aimed to evaluate the improvement of microvasculature after HSCT using NVC. Methods: A total of 16 patients with severe dcSSc with a "late'' videocapillaroscopy pattern underwent an immunesuppressive treatment: 6 were treated with HSCT and 10 with monthly pulse cyclophosphamide (CYC) 1 g for 6 months and then orally with 50 mg/day for further 6 months. NVC was performed before and after 3 months from the beginning of each treatment and then repeated every 3 months. Results: In all patients, before HSCT NVC showed large avascular areas and ramified capillaries and vascular architectural disorganisation ("late'' pattern). At 3 months after HSCT, the NVC pattern changed from "late'' into "active'', showing frequent giant capillaries (>6/mm) and haemorrhages, absence of avascular areas and angiogenesis phenomena; 1 year after HSCT, microvascular abnormalities were still in the "active'' pattern. In patients treated with CYC, no NVC modifications were observed during 24 months of follow-up and the pattern always remained "late''. Conclusions: These results indicate that HSCT with a high dose CYC regimen may foster vascular remodelling, while CYC at lower doses and with a chronic regimen does not influence the microvasculature.
引用
收藏
页码:94 / 98
页数:5
相关论文
共 50 条
  • [41] Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures
    Assassi, Shervin
    Wang, Xuan
    Chen, Guocai
    Goldmuntz, Ellen
    Keyes-Elstein, Lynette
    Ying, Jun
    Wallace, Paul K.
    Turner, Jacob
    Zheng, W. Jim
    Pascual, Virginia
    Varga, John
    Hinchcliff, Monique E.
    Bellocchi, Chiara
    McSweeney, Peter
    Furst, Daniel E.
    Nash, Richard A.
    Crofford, Leslie J.
    Welch, Beverly
    Pinckney, Ashley
    Mayes, Maureen D.
    Sullivan, Keith M.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (10) : 1371 - 1378
  • [42] Second autologous haematopoietic stem cell transplantation in systemic sclerosis-a case report
    van Rhijn-Brouwer, Femke C. C.
    Spierings, Julia
    van Rhenen, Anna
    Kuball, Jurgen
    van Laar, Jacob M.
    RHEUMATOLOGY, 2019, 58 (07) : 1305 - 1307
  • [43] Autologous stem cell transplantation for severe systemic sclerosis: Update on the ASTIS-trial
    van Laar, Jacob M.
    Farge, Dominique
    Tyndall, Alan
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S623 - S624
  • [44] Impact of autologous hematopoietic stem cell transplantation on the quality of life of systemic sclerosis patients
    Cardoso, E. A. D. O.
    Guimaraes, A. L.
    Garcia, J.
    Dias, J.
    Moraes, D.
    Pereira, K.
    Stracieri, A. B.
    Simoes, B.
    Oliveira, M. C.
    Santos, M. A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S538 - S538
  • [45] AMIFOSTINE ADDITION TO CONDITTIONIG REGIMEN IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR SEVERE SYSTEMIC SCLEROSIS
    Reyes, E.
    Avila-Portillo, L. M.
    Arbelaez, A.
    Ospino, B.
    Jaimes, D. A.
    Bello, J.
    Londono, J.
    Valle, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S157 - S157
  • [46] Acquired haemophilia A in a patient with systemic sclerosis treated with autologous haematopoietic stem cell transplantation
    De Langhe, Ellen
    Lenaerts, Jan
    Dierickx, Daan
    Hendrickx, Peter
    Verleden, Geert M.
    Wuyts, Wim A.
    Peerlinck, Kathelijne
    Westhovens, Rene
    RHEUMATOLOGY, 2015, 54 (01) : 196 - 197
  • [47] Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease
    Bagnato, Gianluca
    Versace, Antonio Giovanni
    La Rosa, Daniela
    De Gaetano, Alberta
    Imbalzano, Egidio
    Chiappalone, Marianna
    Ioppolo, Carmelo
    Roberts, William Neal
    Bitto, Alessandra
    Irrera, Natasha
    Allegra, Alessandro
    Pioggia, Giovanni
    Gangemi, Sebastiano
    CELLS, 2022, 11 (05)
  • [48] Autologous stem cell transplantation for severe systemic sclerosis:: update on the ASTIS-trial
    van Laar, J.
    Farge, D.
    Bocelli-Tyndall, C.
    Sont, J.
    Saccardi, R.
    Miniati, I.
    Matucci-Cerinic, M.
    Machold, K.
    Arfi, S.
    Adoue, D.
    Sarrot-Reynauld, F.
    Constans, J.
    Roblot, P.
    Quere, I.
    Durand, J.
    Sibilia, J.
    Himsel, A.
    Kaltwasser, J.
    Peter, H.
    Koetter, I.
    Kleinert, S.
    Tony, H.
    Fassas, A.
    Voskuyl, A.
    Vonk, M.
    van den Hoogen, F.
    Villiger, P.
    Weiner, S.
    Dass, S.
    Emery, P.
    Gratwohl, A.
    Tyndall, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S96 - S96
  • [49] Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis
    Y Oyama
    W G Barr
    L Statkute
    T Corbridge
    E A Gonda
    B Jovanovic
    A Testori
    R K Burt
    Bone Marrow Transplantation, 2007, 40 : 549 - 555
  • [50] Autologous hematopoietic stem cell transplantation: A successful treatment for early severe systemic sclerosis
    Del Papa, N.
    Maglione, W.
    Comina, D. P.
    Vener, C.
    Annaloro, C.
    Della Volpe, A.
    Giordano, R.
    Onida, F.
    Deliliers, G. Lambertenghi
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 207 - 208